Search Results - Cahn, P

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Impairment by Mucosal Adjuvants and Cross-Reactivity with Variant Peptides of the Mucosal Immunity Induced by Injection of the Fusion Peptide PADRE-ELDKWA

    Impairment by Mucosal Adjuvants and Cross-Reactivity with Variant Peptides of the Mucosal Immunity Induced by Injection of the Fusion Peptide PADRE-ELDKWA by Decroix, Nipa, Pamonsinlapatham, Perayot, Quan, Cahn P., Bouvet, Jean-Pierre

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    HCV RNA decline in the first 24 hours exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin

    HCV RNA decline in the first 24 hours exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon... by Laufer, N, Bolcic, F, Rolón, MJ, Martinez, A, Reynoso, R, Pérez, H, Salomón, H, Cahn, P, Quarleri, J

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Improving care for women living with HIV: initial outcomes of an integration experience

    Improving care for women living with HIV: initial outcomes of an integration experience by Fink, V, Zurita, D, Tejo, M, Perez, H, Cesar, C, Figueroa, M, Patterson, P, Sued, O, Cahn, P

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older

    Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older by Patterson, P, Cahn, S, Sued, O, Fink, V, Figueroa, M, Cesar, C, Rojo, M, Ben, G, Vázquez, M, Cahn, P

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Hepatitis B Virus Genotype Distribution and Its Lamivudine-Resistant Mutants in HIV-Coinfected Patients with Chronic and Occult Hepatitis B

    Hepatitis B Virus Genotype Distribution and Its Lamivudine-Resistant Mutants in HIV-Coinfected Patients with Chronic and Occult Hepatitis B by Quarleri, J., Moretti, F., Bouzas, M.B., Laufer, N., Carrillo, M. Gómez, Giuliano, S. Fernández, Pérez, H., Cahn, P., Salomon, H.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection

    Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection by Turk, G, Laufer, N, Rodriguez, AM, Ghiglione, Y, Favilene, J, Ruiz, MJ, Sued, O, Giavedoni, L, Cahn, P, Salomon, H, Gherardi, MM

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

    Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. by Warren, R Q, Wong, M T, Melcher, G P, Blatt, S P, Cahn, P, Perez, H, Zapiola, I, Bouzas, M B, Muchinik, G, Anderson, S A

    Published 1995
    Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents

    Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents by Salazar, J.C., Cahn, P., Yogev, R., Negra, M. Della, Castelli-Gattinara, G., Fortuny, C., Flynn, P., Giaquinto, C., Ruan, P., Smith, M., Mikl, J., Jelaska, A.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

    Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients by Cohen, C, Molina, JM, Cahn, P, Clotet, B, Fourie, J, Grinsztejn, B, Hao, W, Johnson, M, Supparatpinyo, K, Crauwels, HM, Rimsky, L, Vanveggel, S, Williams, P, Boven, K

    Published 2010
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART

    Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART by Cahn, P, Leite, O, Rosales, A, Cabello, R, Alvarez, CA, Seas, C, Carcamo, C, Cure-Bolt, N, L'Italien, Gp, Mantilla, P, Deibis, L, Zala, C, Suffert, T

    Published 2010
    Get full text
    Online
    Save to List
    Saved in:
  11. 11
    Prioritising prevention strategies for patients in Antiretroviral Treatment Programmes in Resource-Limited Settings

    Prioritising prevention strategies for patients in Antiretroviral Treatment Programmes in Resource-Limited Settings by SPAAR, A., GRABER, C., DABIS, F., COUTSOUDIS, A, BACHMANN, L., MCINTYRE, J., SCHECHTER, M., PROZESKY, H.W., TUBOI, S., DICKINSON, D., KUMARASAMY, N., PUJDADES-RODRIQUEZ, M., SPRINZ, E., SCHILTHUIS, H.J., CAHN, P., LOW, N., EGGER, M.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: